NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN – Theravance Biopharma, Inc. Transaction History
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN portfolio value:
$590,000
portfolio value
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN quarter portfolio value change:
+11.92%
quarter
Theravance Biopharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 63K | $10.14 | 58.14K | |
| Q2 2022 | share | 0.00% | 0 shares | -28K | $9.06 | 58.14K | |
| Q1 2022 | share | 0.00% | 0 shares | -87K | $9.56 | 58.14K | |
| Q4 2021 | share | 0.00% | 0 shares | 211K | $10.98 | 58.14K | |
| Q3 2021 | share | 0.00% | 0 shares | -413K | $7.4 | 58.14K | |
| Q2 2021 | share | 0.00% | 0 shares | -343K | $14.52 | 58.14K | |
| Q1 2021 | share | Increase | +52.44% | 20K shares | 510K | $20.41 | 58.14K |
| Q4 2020 | share | 0.00% | 0 shares | 113K | $17.77 | 38.14K | |
| Q3 2020 | share | 0.00% | 0 shares | -237K | $14.79 | 38.14K | |
| Q2 2020 | share | 0.00% | 0 shares | -80K | $20.99 | 38.14K | |
| Q1 2020 | share | 0.00% | 0 shares | -107K | $23.11 | 38.14K | |
| Q4 2019 | share | 0.00% | 0 shares | 245K | $25.89 | 38.14K | |
| Q3 2019 | share | Increase | +22.48% | 7K shares | 235K | $19.48 | 38.14K |
| Q2 2019 | share | 0.00% | 0 shares | -198K | $16.33 | 31.14K | |
| Q1 2019 | share | Increase | +6.86% | 2K shares | -40K | $22.67 | 31.14K |
| Q4 2018 | share | Decrease | -14.64% | -5K shares | -369K | $25.59 | 29.14K |
| Q3 2018 | share | 0.00% | 0 shares | 341K | $32.67 | 34.14K | |
| Q2 2018 | share | 0.00% | 0 shares | -54K | $22.68 | 34.14K | |
| Q1 2018 | share | 0.00% | 0 shares | -124K | $24.25 | 34.14K | |
| Q4 2017 | share | Increase | +41.42% | 10K shares | 125K | $27.89 | 34.14K |
| Q3 2017 | share | Decrease | -51.01% | -25.14K shares | -1.13M | $34.24 | 24.14K |
| Q2 2017 | share | 0.00% | 0 shares | 149K | $39.84 | 49.28K | |
| Q1 2017 | share | 0.00% | 0 shares | 244K | $36.82 | 49.28K | |
| Q4 2016 | share | 0.00% | 0 shares | -215K | $31.88 | 49.28K | |
| Q3 2016 | share | 0.00% | 0 shares | 668K | $36.24 | 49.28K | |
| Q2 2016 | share | 0.00% | 0 shares | 91K | $22.69 | 49.28K | |
| Q1 2016 | share | 0.00% | 0 shares | 219K | $18.8 | 49.28K |